0001209191-23-037906.txt : 20230616 0001209191-23-037906.hdr.sgml : 20230616 20230616163019 ACCESSION NUMBER: 0001209191-23-037906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230614 FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Curnutte John T CENTRAL INDEX KEY: 0001574589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38722 FILM NUMBER: 231021640 MAIL ADDRESS: STREET 1: PORTOLA PHARMACEUTICALS, INC. STREET 2: 270 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchard Therapeutics plc CENTRAL INDEX KEY: 0001748907 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 HAMMERSMITH ROAD, 3RD FLOOR CITY: LONDON STATE: X0 ZIP: W6 8PW BUSINESS PHONE: 011-44-0-203-3846700 MAIL ADDRESS: STREET 1: 245 HAMMERSMITH ROAD, 3RD FLOOR CITY: LONDON STATE: X0 ZIP: W6 8PW FORMER COMPANY: FORMER CONFORMED NAME: Orchard Rx Ltd DATE OF NAME CHANGE: 20180802 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-14 0 0001748907 Orchard Therapeutics plc ORTX 0001574589 Curnutte John T C/O ORCHARD THERAPEUTICS PLC 245 HAMMERSMITH ROAD LONDON X0 W6 8PW UNITED KINGDOM 1 0 0 0 0 Stock Option (Right to Buy) 0.495 2023-06-14 4 A 0 105000 0.00 A 2033-06-13 Ordinary Shares 105000 105000 D All of the shares subject to this option vest upon the earlier to occur of June 14, 2024 or the date of the 2024 Annual General Meeting of the Company. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares. /s/ Frank Thomas, as attorney-in-fact 2023-06-16